(Q35610513)

9 August 2017

1 reference

title

Pharmacogenomics and breast cancer (English)

1 reference

9 August 2017

1 reference

Stella C Lymberis

1

1 reference

9 August 2017

Preeti K Parhar

series ordinal

2

1 reference

9 August 2017

Evangelia Katsoulakis

series ordinal

3

1 reference

9 August 2017

Silvia C Formenti

series ordinal

4

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

5

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

31-55

1 reference

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

BRCA2 associates with acetyltransferase activity when bound to P/CAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Activation and activities of the p53 tumour suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

p53 polymorphisms and haplotypes in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The genetic defect in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genotype-phenotype relationships in ataxia-telangiectasia and variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Characterization of ATM gene mutations in 66 ataxia telangiectasia families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Breast and other cancers in families with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Heterozygous ATM mutations do not contribute to early onset of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

"Other" breast cancer susceptibility genes: searching for more holy grail

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The function of BRCA1 in DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Human DNA repair systems: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

XRCC1 genetic polymorphism and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

XRCC3 is required for efficient repair of chromosome breaks by homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Variants in DNA double-strand break repair genes and breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Endogenous sex hormone levels and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Low penetrance genes associated with increased risk for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Tissue-specific, cyclic adenosine 3',5'-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Aromatase and breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Progesterone receptor gene polymorphism and risk for breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Serum sex hormone levels after menopause and subsequent breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Sex hormones and postmenopausal breast cancer: a prospective study in an adult community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

21 January 2018

Inhibitors of integrins

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Integrin activation controls metastasis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Integrin beta3 Leu33Pro homozygosity and risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Transforming growth factor-beta in breast cancer: a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphic analysis of the three MHC-linked HSP70 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Population and family studies of dihydropyrimidinuria: prevalence, inheritance mode, and risk of fluorouracil toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Pharmacogenetics in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Individual variation and dose dependency in the progression rate of skin telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Conc

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Increased Radiosensitivity of Normal Tissue Fibroblasts in Patients with Acquired Immunodeficiency Syndrome (AIDS) and with Kaposi's Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Absence of ATM truncations in patients with severe acute radiation reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Transforming growth factor-beta activation in irradiated murine mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Superoxide radical and superoxide dismutases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's di

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

SNPs and pharmacogenomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genetic Polymorphisms of Platelet Adhesive Molecules: Association with Breast Cancer Risk and Clinical Presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Estrogen Receptor Polymorphism at Codon 325 and Risk of Breast Cancer in Women Before Age Forty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Localization of the gene for Cowden disease to chromosome 10q22–23

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Role of Estradiol Metabolism and CYP1A1 Polymorphisms in Breast Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Patient-to-patient variability in the expression of radiation-induced normal tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

p53 Mutations, Polymorphisms, and Haplotypes in Pakistani Ethnic Groups and Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Variability in loss of constitutional heterozygosity across loci and among individuals: association with candidate genes in ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

p53 polymorphisms and haplotypes in different ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

p53 polymorphism in ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A novel polymorphism in intron 6 of the human p53 gene: a possible association with cancer predisposition and susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The ATM gene and breast cancer: is it really a risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

RESPONSE: re: HRAS1 rare minisatellite alleles and breast cancer in australian women under age forty years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Unexpected Right Phrenic Nerve Injury During 5-Fluorouracil Continuous Infusion Plus Cisplatin and Vinorelbine in Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A rare CYP19 (aromatase) variant may increase the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genetic variants of CYP19 (aromatase) and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Sex hormone levels in serum in relation to the development of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genetic control of the circulating concentration of transforming growth factor type beta1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Known variant DPYD alleles do not explain DPD deficiency in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Dihydropyrimidinuria: a new inborn error of pyrimidine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Dose and volume effects on fibrosis after breast conservation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Evidence for individual differences in the radiosensitivity of human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Prognostic factors for acute and late skin reactions in radiotherapy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

In vitro radiosensitivity and normal tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Diversity ofATM gene mutations detected in patients with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Modulation of oxygen-radical-scavenging enzymes by oxidative stress in primary cultures of rat astroglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2FPHGS.5.1.31.25686

10.1517/PHGS.5.1.31.25686

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference